🎥 The final AIDA webinar is live! Miriam Cuatrecasas, Glória Fernández-Esparrach & Leticia Moreira explore precursor lesions of gastric cancer. 👉 Watch the full session with English subtitles: https://t.co/l2qnsCghbz

It was our pleasure to host the autumn EORTC - European Organisation for Research and Treatment of Cancer GI group meeting in Valencia. Thanks to @LizzySmyth1 and Francesco Sclafani for their leadership and to all members for the great inputs and discussion.@EORTC @incliva_iis

Nuestro sincero agradecimiento de ❤️ a @_SEOM y a los amigos y familiares de #retodeRober por la beca concedida a nuestro grupo para investigación en cáncer gástrico. Comprometidos con nuestros pacientes y la investigación. @incliva_iis @GVAclinic

🎧 New @myESMO GI podcast! Get the latest insights on upper GI cancers 🔑 updates on oesophageal & #gastric cancer from the #ESMOCongress 2025 @FilippoPietran4 @tfleitask 🔈Listen now: 🔗 https://t.co/haOKpDDjr0 🔗 https://t.co/7M3recvWqw #Oncology #GIcancer #CancerResearch

Study reveals an AI system that achieved a 94.1% success rate in personalising H. pylori treatment. Researchers led by Dr @KirillVeselkov from @imperialcollege have developed an AI Clinician system that tailors treatment. 🔗Further reading: https://t.co/1vvrsotNjJ

Happy #LegacyH2020 reunion at #ESMO Berlin 2025! 😀 with Sarah Derks, Andres Cervantes, Rodrigo Dientsmann, Maria Alsina!

We have seen the mountain ⛰️ top! MATTERHORN OS #ESMO25 OS continues to ⬆️over time (~7% 3y) Benefit independent of PD-L1 Enough now to adopt as SOC? #ESMOAmbassadors

📌New in @ESMO_Open: 🎯Tumor Boards can guide matched therapies for ESCAT II-III alterations. Patients had median OS 31 vs 11 months. 🏥Study conducted at @incliva_iis @GVAsanitat, led by @Desam_Roda @ValeGambardella 🔗 https://t.co/RS6dAbL8uS

🌍 On #WorldCancerResearchDay we highlight Prof. Tamara Matysiak-Budnik (CHU de Nantes, AIDA partner): 🗣️ “To improve prevention & early detection of gastric cancer, we must better understand its mechanisms—only research, clinical & fundamental, can achieve this.”

📍#TTDCOLOQUIO 'Dianas terapéuticas en cáncer gástrico/UGE: necesidades hoy y mañana-HER negativo' 📅23-S ⏰17h Coordina: Dr.Rivera, presidente TTD(@HUnivValdecilla)📢Dras.Fleitas; Calvo; Martínez Patrocina @AstellasEurope BeOne https://t.co/oNoswA3Ys4 ✅Abierto a especialistas

👉 For ESMO Members! ESMO Handbook of Cancer Genetics and Genomics Edited by leading experts, delivering genomic literacy for clinical decision making: inherited genetic syndromes, key somatic and germline mutations, and more! 🔗 Download now: https://t.co/mbtzCXu63F

Motivating Day 2 at the ESMO Gastric Cancer preceptorship! Great learning insights in advanced gastric cancer management! Looking forward for the clinical cases discussion !

Day 1 at the ESMO Gastric Cancer Preceptorship 🇪🇸 Kicking off with powerful insights and great company. Grateful to @myESMO for the great organisation! #ESMO #GastricCancer #Oncology #Day1 #Madrid

🎙️ Hot off post #ESMOGI Barcelona. The new ESMO #UpperGI podcast delivers key updates for #GEA. @FilippoPietran4 @tfleitask @ben_irit Listen now 👉

🧠An AIDA study reviews advanced AI models to detect Gastric Intestinal Metaplasia, a precancerous condition linked to gastric cancer. Early detection saves lives. AI can help! 👉 https://t.co/4tq2Rr3xU5

🎙️ New #ESMO Podcast – Controversies in Upper GI Cancers 📌 Radiotherapy in borderline resectable #PDAC: Evidence vs practice – when does it make sense? @NiuSanford & @BasGrootKoerkam join me to discuss a case & key trials. 🎧 Listen: https://t.co/mgtMiKFkUI #PancreaticCancer

Happy to share initial report on temporal change of CLDN18.2 after chemo + zolbetuximab: ~50% showed decreased expression (<75%+ cells) on PD, but 75% retained ≥25% expression—supporting potential for other CLDN-targeted tx like ADCs @ESMO_Open @myESMO   https://t.co/9d34uIRTcS

🎧 Another @myESMO Upper GI podcast! We break down key #ASCO25 updates in #EsophagealCancer & #GastricCancer: ✔️ CheckMate 577 ✔️ Matterhorn ✔️ DESTINY-Gastric04 ✔️ SATRi-cel (CAR-T!) With @LizzySmyth1, Sylvie Lorenzen & @ThAlcin 🎙 Listen now: https://t.co/yXBTS5k5NV #GIonc

🎧 New @myESMO upper GI podcast! We unpack key #ASCO25 updates in #PancreaticCancer & #BiliaryCancer: ✔️ CASSANDRA ✔️ PANOVA-3 ✔️ Elraglusib ✔️ GAIN & POLCA-GB w/ @ArndtVogel & Florian Castet 🎙 Listen: https://t.co/piDDivgNtQ #GIonc

Can artificial intelligence outperform human clinicians in selecting personalized treatments for the world's most common carcinogenic infection that affects nearly half the global population?@NatureComms @UAM_Madrid "The Helicobacter pylori AI-clinician harnesses artificial